Mario Balsa/X
Aug 7, 2025, 09:33
Mario Balsa: Systematic Review of CLDN18.2 in Advanced Gastric/GEJ Adenocarcinoma
Mario Balsa, Medical Oncology Resident at Catalan Institute of Oncology, shared a post on X, about a recent article by M. Fassan et al. published in ESMO Gastrointestinal Oncology
“Systematic review of CLDN18.2 in advanced gastric/GEJ adenocarcinoma:
- 17 studies, mixed findings
- No consistent link to survival or clinico-path features
- Variability in assays limits conclusions
Prognosis remains…a tight junction to solve.”
Title: The prognostic role of Claudin 18.2 in advanced gastric or gastroesophageal junction adenocarcinoma: a systematic literature review
Authors: M. Fassan, I. Chau, H. Dasghaib, J. Hill, R. Pophale, K. Shitara
Read the Full Article on ESMO Gastrointestinal Oncology
More posts featuring Mario Balsa.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Aug 7, 2025, 09:16
Aug 7, 2025, 08:27
Aug 7, 2025, 08:18
Aug 6, 2025, 22:57
Aug 6, 2025, 22:41
Aug 6, 2025, 22:14